Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 15

Financial Times

Pfizer and BioNTech have enrolled the first participants in a clinical trial of a vaccine tailored to the Omicron coronavirus variant as the companies